These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 39123106)

  • 1. Immune and inflammation features of severe and critical Omicron infected patients during Omicron wave in China.
    Liu Y; Guo Y; Zhan H; Liu X; Li X; Cui J; Li H; Feng S; Cheng L; Li X; Guo S; Li Y
    BMC Infect Dis; 2024 Aug; 24(1):809. PubMed ID: 39123106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between immunity and viral shedding duration in non-severe SARS-CoV-2 Omicron variant-infected patients.
    He S; Fang Y; Yang J; Wang W
    Front Public Health; 2022; 10():1032957. PubMed ID: 36620263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critically ill children with SARS-COV-2 Omicron infection at a national children medical center, Guangdong, China.
    Lin F; Jiang DJ; Zhang S; Yang Z; Zeng HS; Liu ZP; Yang LY
    BMC Pediatr; 2024 Apr; 24(1):254. PubMed ID: 38622552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
    Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
    Front Immunol; 2021; 12():700921. PubMed ID: 34539631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses during COVID-19 breakthrough cases in vaccinated children and adolescents.
    Rivera-Pérez D; Méndez C; Diethelm-Varela B; Melo-González F; Vázquez Y; Meng X; Xin Q; Fasce RA; Fernández J; Mora J; Ramirez E; Acevedo ML; Valiente-Echeverría F; Soto-Rifo R; Grifoni A; Weiskopf D; Sette A; Astudillo P; Le Corre N; Abarca K; Perret C; González PA; Soto JA; Bueno SM; Kalergis AM
    Front Immunol; 2024; 15():1372193. PubMed ID: 38812507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China.
    Zeng Z; Yu H; Chen H; Qi W; Chen L; Chen G; Yan W; Chen T; Ning Q; Han M; Wu D
    Crit Care; 2020 Aug; 24(1):525. PubMed ID: 32854750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection.
    Horspool AM; Kieffer T; Russ BP; DeJong MA; Wolf MA; Karakiozis JM; Hickey BJ; Fagone P; Tacker DH; Bevere JR; Martinez I; Barbier M; Perrotta PL; Damron FH
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33472985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
    Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
    Front Immunol; 2020; 11():596684. PubMed ID: 33362779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analyze the clinical characteristics of mild and severe SARS-CoV-2 infected patients based on the local Omicron variant epidemic].
    Yan Y; Lyu C; Davgadorj C; Wang X; Sha M
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Jan; 35(1):32-36. PubMed ID: 36880235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and imaging analysis of neurological complications in critically ill children infected with SARS-CoV-2 Omicron].
    Wang X; Qi X; Zhao Y; Wei F; Yang W; Zeng H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Nov; 35(11):1157-1163. PubMed ID: 37987125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease-duration based comparison of subsets of immune cells in SARS CoV-2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity.
    Kulkarni-Munje A; Palkar S; Shrivastava S; Lalwani S; Mishra AC; Arankalle VA
    Immun Inflamm Dis; 2021 Jun; 9(2):419-434. PubMed ID: 33452858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response against the SARS-CoV-2 spike protein in cancer patients after COVID-19 vaccination during the Omicron wave: a prospective study.
    Muñoz-Gómez MJ; Ryan P; Quero-Delgado M; Martin-Vicente M; Cuevas G; Valencia J; Jiménez E; Blanca-López N; Lara-Álvarez MÁ; Hernández-Rivas JÁ; Redondo G; Mas V; Sepúlveda-Crespo D; Vázquez M; Torres-Macho J; Martínez I; Resino S
    J Infect Public Health; 2024 Jul; 17(7):102473. PubMed ID: 38865774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.
    Liu Y; Tan W; Chen H; Zhu Y; Wan L; Jiang K; Guo Y; Tang K; Xie C; Yi H; Kuang Y; Luo Y
    BMC Infect Dis; 2021 Jan; 21(1):79. PubMed ID: 33461503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis.
    Qin R; He L; Yang Z; Jia N; Chen R; Xie J; Fu W; Chen H; Lin X; Huang R; Luo T; Liu Y; Yao S; Jiang M; Li J
    Clin Rev Allergy Immunol; 2023 Feb; 64(1):33-65. PubMed ID: 35040086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.
    Sasson JM; Campo JJ; Carpenter RM; Young MK; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Teng AA; Pablo JV; Liang X; Yee A; Petri WA; Camerini D
    mBio; 2021 Jun; 12(3):e0122921. PubMed ID: 34182775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics of children with SARS-CoV-2 Omicron variant infection in Kunming].
    Yang JW; Tang CH; Dai M; Duan J; Li YH; Yang J; Yang T; Gao Y; Ban D; Zhu JC; Yuan TY; Li Y; Fu HM
    Zhonghua Er Ke Za Zhi; 2023 Oct; 61(10):922-927. PubMed ID: 37803860
    [No Abstract]   [Full Text] [Related]  

  • 19. Neutralizing Antibody Responses against Five SARS-CoV-2 Variants and T Lymphocyte Change after Vaccine Breakthrough Infections from the SARS-CoV-2 Omicron BA.1 Variant in Tianjin, China: A Prospective Study.
    Zhang Y; Qu JW; Zheng MN; Ding YX; Chen W; Ye SD; Li XY; Li YK; Liu Y; Zhu D; Jin CR; Wang L; Yang JY; Zhai Y; Wang EQ; Meng X
    Biomed Environ Sci; 2023 Jul; 36(7):614-624. PubMed ID: 37533385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines and their relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19): a retrospective cohort study.
    Liu QQ; Cheng A; Wang Y; Li H; Hu L; Zhao X; Wang T; He F
    BMJ Open; 2020 Nov; 10(11):e041471. PubMed ID: 33257492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.